WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

Medtronic pays about $700M for rights to sell Cornerstone Robotics' Sentire outside the US Globus Medical wins a CE mark for Excelsius3D five years after FDA clearance GE HealthCare software updates dropped patients from monitoring, now a Class II recall Boston Scientific pulls Imager II catheters over degrading tips and ends the product line MiniMed wins a CE mark for the Flex insulin pump ahead of its year-end target Boston Scientific restarts shipping a week after the August 25 cyberattack ArthroTAK gets a second 510(k), adding knee tenodesis to its sutureless tendon anchor Oura files S-1 for Nasdaq IPO with $1.21B in nine-month revenue and 5 million paid members FDA confirms a Class I recall of Boston Scientific Infinion CX leads after 1,081 serious injuries Medtronic pays about $700M for rights to sell Cornerstone Robotics' Sentire outside the US Globus Medical wins a CE mark for Excelsius3D five years after FDA clearance GE HealthCare software updates dropped patients from monitoring, now a Class II recall Boston Scientific pulls Imager II catheters over degrading tips and ends the product line MiniMed wins a CE mark for the Flex insulin pump ahead of its year-end target Boston Scientific restarts shipping a week after the August 25 cyberattack ArthroTAK gets a second 510(k), adding knee tenodesis to its sutureless tendon anchor Oura files S-1 for Nasdaq IPO with $1.21B in nine-month revenue and 5 million paid members FDA confirms a Class I recall of Boston Scientific Infinion CX leads after 1,081 serious injuries

Cyberattack

Boston Scientific tells the SEC it will miss 2026 guidance after the August cyberattack

MedDevice Startups Staff · 22 hrs ago · 2 min read · Via MedTech Dive

Boston Scientific told the SEC on September 8 that it is unlikely to meet its third quarter and full year sales and earnings guidance because of the cyberattack that hit its systems in late August. The July guidance called for 5.5% to 6.5% sales growth and adjusted EPS of $3.22 to $3.28. Shares fell more than 4% to $45.73 that morning.

The intrusion disrupted manufacturing, order processing and shipping. The company said distribution centers are now running at or above normal levels and that it expects to recover some of the lost revenue as backlogs clear. A new outlook comes on the October 28 earnings call.

Boston Scientific restored shipping on September 4 and pulled its guidance four days later. Systems recovery and revenue recovery run on separate clocks, which is the distinction a hospital customer or an acquirer will press a smaller supplier on after any incident.

Questions & Answers

How is the Boston Scientific cyberattack affecting its 2026 financial guidance?

Boston Scientific said in a September 8, 2026 SEC filing that it is unlikely to meet its third quarter and full year 2026 sales growth and adjusted earnings per share guidance. The July guidance had called for 5.5% to 6.5% sales growth and adjusted EPS of $3.22 to $3.28.

When did the Boston Scientific cyberattack happen and what did it disrupt?

The cyberattack hit Boston Scientific in late August 2026 and disrupted manufacturing, order processing and shipping. The company began restoring shipping on September 4, 2026 and says its distribution centers are now processing at or above normal levels.

When will Boston Scientific give an updated outlook after the cyberattack?

Boston Scientific said it will provide an updated financial outlook on its earnings call scheduled for October 28, 2026.

← Back to Cybersecurity